Innate Pharma

time minute
Biotech

Innate says lymphoma data shows anti-KIR3DL2 antibody’s promise

Innate Pharma has produced long-term data showing that its anti-KIR3DL2 antibody has a “sustained effect” against two types of lymphoma.
James Waldron May 23, 2025 5:13am
Sanofi

Sanofi hands cancer drug to Innate as it pivots R&D pact focus

Apr 23, 2025 6:35am
An artists impression of natural killer cells which look like fluffy pink orbs descending upon and attacking a purple vas

Innate antibody pits NK cells against lymphoma in animal models

Nov 15, 2024 2:00pm
Parachute over La Jolla California

Less than a year in, BenevolentAI CEO is out—Chutes & Ladders

Oct 18, 2024 8:30am
pipeline new drugs pipes faucet

Innate drops monotherapy plans for lacutamab in type of lymphoma

Mar 21, 2024 8:27am
parachute sunset flying

Scorpion taps new CEO, CMO—Chutes & Ladders

Jan 5, 2024 9:30am